-
-
-
-
-
-
For clinicians who are involved in care of HIV-infected patients, the newly revised Guidelines for the Use of Antiretroviral Agents In HIV-1-Infected Adults and Adolescents contains key treatment updates, as well as a new section on costs, including discussion of cost-sharing, prior authorizations, and use of generic drugs.
-
The Centers for Disease Control and Prevention has just issued updated resources for genital herpes clinical training. At least one in six adolescents and adults in the United States are infected with herpes simplex virus type 2 (HSV-2), with an estimated 776,000 new cases occurring each year.
-
Injectable contraception in the form of depot medroxyprogesterone acetate (DMPA) provides birth control for women who desire convenience, but are unable to use or do not want to commit to a long-acting reversible contraceptive.
-
While progress has been made in reducing teen pregnancy rates, many adolescents still are having babies, according to new data from the Centers for Disease Control and Prevention. While births to younger teens ages 15-17 have declined, they still represent over one-quarter of births to teens ages 15-19, which is nearly 1,700 births a week.
-
The Food and Drug Administration (FDA) has for the first time approved a human papillomavirus (HPV) test that can be used alone instead of the Pap test to screen for cervical cancer.